4-oxo-1H-quinoline-3-carboxamides as modulators of ATP-Binding cassette transporters

Details for Australian Patent Application No. 2010327993 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Sheth, Urvi; Fanning, Tev T.D.; Numa, Mehdi; Binch, Hayley; Hurley, Dennis James; Zhou, Jinglan; Hadida Ruah, Sara S.; Hazlewood, Anna R.; Silina, Alina; Vairagoundar, Rajendran; Van Goor, Fredrick F.; Grootenhuis, Peter Diederik Jan; Botfield, Martyn C.

Agent Cullens

Pub. Number AU-A-2010327993

PCT Pub. Number WO2011/072241

Priority 12/635,927 11.12.09 US

Filing date 10 December 2010

Wipo publication date 16 June 2011

International Classifications

C07D 215/56 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

A61P 11/00 Drugs for disorders of the respiratory system

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/08 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/072241 Priority application(s): WO2011/072241

19 July 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Vertex Pharmaceuticals Incorporated, Application No. 2010327993, under INID (72) correct the co-inventor to Fanning, Lev T.D. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the date of this Journal. 2007296939 Fidia Farmaceutici S.p.A. 2008256910 Tru Woods Limited 2009251036 Kraft Foods Global Brands LLC 2009251036 Kraft Foods Glob

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010327998-TAL effector-mediated DNA modification

2010327987-Patient-specific and patient-engineered orthopedic implants